n e w s a n d v i e w s voluntary body saccades in the opposite direction (Fig. 1c) . These body saccades were highly correlated with sharp drops in the HSN cell's membrane potential, which was otherwise depolarized on average owing to pattern motion to the right. Pattern movements to the left gave corresponding results with opposite sign (Fig. 1c) .
There is an obvious interpretation to these exciting results: Kim et al. 2 had found strong evidence for the use of efference copies at the level of individually identifiable HS cells, which are an integral component of the feedback loop controlling the fly optomotor response. And the features of these efference copies were pretty much the same as von Holst and Mittelstaedt 1 had postulated in the last century. Kim et al. 2 found efference copies not only in HS cells, sensitive to wide-field motion, but also in a newly characterized class of neurons that respond to small moving objects.
But why does this matter? Providing experimental evidence for something suggested long ago certainly is a major achievement, but what is the added value? In addition, the use of efference copies has already been shown at the cellular level in other systems. Weakly electric fish, for instance, generate an electric field in respecified muscles cells to communicate and to detect and analyze close-by objects in a process called electrolocation. These fish use efference copies that enable them to distinguish the exafferent part from the reafferent signal picked up by its various electroreceptive pathways 9 . And in the auditory system of male crickets, an efference copy was found to prevent the animals from deafening themselves when producing their courtship songs 10 . Finally, alternative ideas have been suggested as to how a mechanosensory feedback loop supporting equilibrium reflexes in Drosophila could be modified when the fly engages in voluntary turns 11 . What difference then does the study by Kim et al. 2 really make?
The answer lies in what we do not yet know, but now possess the foundation to tackle. Two important questions remain open if we want to understand the neural mechanisms underlying the use of efference copy: which parts in the Drosophila brain provide the efference copies and how are the efference copy signals formed? They could be based on correlations between motor commands executed under certain conditions and the resulting reafferent feedback, which shape and update a stored efference copy signal. This would be similar to the way in which efference copies in weakly electric fish contribute to sensory information processing 9 . For Drosophila, however, this is still pure speculation.
Kim et al. 2 have established an experimental means by which the power of an integrated systems approach can be brought to bear on the mechanisms underlying the use of efference copy in the nervous system. Their work on Drosophila has significant potential to go far beyond the explanation of how voluntary movements are enabled. An efference copy essentially is a prediction of the sensory feedback given a particular motor action, often referred to as a forward model. Forward models are thought to be core ingredients for motor planning, refining and redefining motor programs, and ultimately for solving cognitive problems 12, 13 . Being able to study neural processes involving efference copies in Drosophila is likely to help us to identify further general principles of higher brain functions across phyla 14 .
What happens underwater stays underwater. Essentially, that was the conclusion of what became a classic study in psychology conducted some 40 years ago by Godden and Baddeley 1 . The two researchers somehow persuaded a group of divers, who were otherwise enjoying a relaxing holiday in Scotland, to learn a long list of simple words either when they were in the water or on land, and then asked them to freely recall the words in one or the other environment. As Godden and Baddeley had suspected, more words were recalled when the divers were in the same environment, wet or dry, in which they had originally learned them in. This phenomenon is now well-known in psychology as state-dependent learning 2 . It tells us that not only does the external environment direct what we learn and remember, but so too does the internal state of our body and mind. And this applies to all manner of memories. It might even apply to the kinds of memories that are indelibly linked to profoundly traumatic events that can spiral into an anxiety disorder or posttraumatic stress disorder. These disorders have become some of the most prevalent of all psychiatric conditions and place a heavy burden on individuals, their families and society at large. But, although we have been making appreciable progress in drawing an increasingly detailed schematic of the brain circuitry responsible for forming, storing and erasing fear memories 3-5 , we still know surprisingly little about how the brain processes information about state to modulate fear memories.
We now have some important new insights into this question thanks to a study by Jovasevic et al. 6 published in this issue of npg nature neuroscience volume 18 | number 9 | september 2015 n e w s a n d v i e w s Nature Neuroscience. These authors, who have for some years studied the molecular and cellular machinery governing fear memories, were struck by an apparent paradox. They noted that some drugs acting on GABA A receptors disrupted memory, whereas others did not, and in fact could enhance state-dependent learning. One reason for these variable effects, they hypothesized, could lie in known differences in how certain drugs bind to specific subpopulations of GABA A receptors. Specifically, they reasoned that those drugs that target and bind extrasynaptic GABA A receptors might preferentially influence state-dependent fear learning.
The authors set about testing this idea in mice by first infusing gaboxadol, which activates extrasynaptic GABA A receptors, into the hippocampus, a brain region central to the formation of contextual fear memories. One group of mice received drug infusion immediately before they were trained to associate a particular environment with foot shock, whereas another group of mice were infused before testing for retrieval of the fear memory the following day. Both of these groups showed less fear (freezing behavior) during the retrieval test, indicating an impairment in contextual fear memory. In contrast, a third group that was given gaboxadol infusions both before training and before testing had fear levels comparable to controls that had never received the drug. This pattern of results is consistent with hippocampal extrasynaptic GABA A receptors mediating a state-dependent form of contextual fear (Fig. 1) .
How does activating hippocampal GABA A receptors change the intracellular signaling milieu to produce these behavioral effects? Jovasevic et al. 6 went searching for some of the potentially critical molecular events acting downstream of the GABA A receptor. Given prior hints that GABA A receptors phosphorylate protein kinase C (PKC), the authors screened for changes in phosphorylation following gaboxadol administration and pinpointed an upregulation in phosphorylation of PKCβII on Ser660. This molecular change turned out to be a functionally relevant one, as inhibiting PKCβII interfered with the generation of state-dependent contextual fear memory by gaboxadol. Given the growing interest in PKC as a therapeutic target for memory deficits in various brain diseases 7 , it would be worthwhile following up on this finding to further define the role of PKCβII in state-dependent learning and potentially other forms of fear memory.
The authors next turned their attention to another recently reported regulator of GABA A receptors 8 : microRNAs. miRNAs are group of small, noncoding RNAs with a widespread and profound effect on the expression of protein-coding genes 9 . miRNAs are attracting increasing interest, not only as regulators of brain function and behavior, but also as factors moderating risk for psychiatric illnesses 10 , and prior studies have already implicated miRNAs in fear memory formation and other stress-related behaviors 10 . Could they also influence statedependent contextual fear? Beginning with the profiling of miRNAs that were differentially expressed in the hippocampus after fear conditioning, Jovasevic et al. 6 whittled down the list of potential miRNA candidates to one, miR-33, which they postulated might target several mRNAs encoding GABA A receptors and be decreased by a combination of fear training and gaboxadol.
The road of many studies in neuroscience leads ultimately to the question of causality. In this case, the question is whether miR-33 gates the capacity of extrasynaptic GABA A receptors to produce state-dependent fear memories. Jovasevic et al. 6 tackled this question with viral constructs that, when infused into the hippocampus, allowed the researchers to either increase or decrease miR-33 locally. Using these tools, they found that overexpressing miR-33 was sufficient to disrupt the memory-impairing effects of single intrahippocampal gaboxadol infusions given before training or testing, but did not prevent the state dependency produced by drug infusion before both training and testing. They also found that virus-mediated miR-33 knockdown induced a state dependent-like fear memory when combined with a pre-training and pre-testing subthreshold dose of gaboxadol that, when administered alone, was insufficient to generate state dependency. On the basis of these data, the authors concluded that levels of miR-33 in the hippocampus set the bar for GABA A receptor-mediated state-dependent memory, with low miR-33 enabling state dependency, but high miR-33 not sufficient to occlude it. Under normal, drug-free circumstances, pairing a distinct context with foot shock (training) generates a robust fear memory for that context, as indicated by freezing on context reexposure (testing). When extrasynaptic GABA A receptors are activated in the hippocampus by infusing gaboxadol either before training or before testing, freezing during the test is low, suggesting that the contextual fear memory has been disrupted, perhaps because its expression is dependent on the simultaneous engagement of hippocampal GABA A receptors. Consistent with the generation of a state-dependent memory by GABA A receptors, infusing gaboxadol into the hippocampus before both training and testing produced robust expression of the contextual fear memory. Thus, hippocampal GABA A receptors generate a neural state that gates context fear. 
Although altering levels of hippocampal miR-33 clearly affected memory, miR-33 is not a specific regulator of GABA A receptors, and the observed phenotype could well be mediated by changes in multiple miR-33 targets in the hippocampus. In this regard, it will be important to tie the various strands of evidence together and establish a plausible link between miR-33, memory and the GABA A receptor. This question awaits resolution in future work, but Jovasevic et al. 6 do provide initial hints by showing that virally altering levels of miR-33 changes the hippocampal expression of known regulators of the GABA A receptor, such as synapsin-2.
Jovasevic et al. 6 sought to add one final piece to their puzzle and asked how activating the GABA A receptor in the hippocampus recruits a broader brain network to shape state-dependent fear. To do so, they quantified the expression of immediate early gene responses (c-Fos and early growth factor 1) in hippocampal projections areas after mice had been tested for gaboxadol-induced statedependent contextual memory. They found an increase in neural activation in the dentate gyrus and lateral septum, but a decrease in the retrosplenial cortex. Although it is unclear whether this pattern of neural recruitment is unique to a GABA A receptor-generated statedependent memory, it would fit with the notion of a functional rebalancing of the extended hippocampal circuit in favor of subcortical regions at the expense of the retrosplenial cortex, as state-dependent fear memories are formed.
Jovasevic et al. 6 further bolstered this idea by inactivating the retrosplenial cortex pharmacogenetically using DREADD (designer receptors exclusively activated by designer drugs). Inactivation before retrieval impaired contextual fear in undrugged controls, but appeared to further strengthen a gaboxadolinduced state-dependent contextual memory. Thus, engagement of this cortical area may have a dual role, acting to support the retrieval of contextual fear memories, but suppress fear memories that are state dependent-at least those driven by GABA A receptor activation. This speaks to one of the key messages from the findings: state-dependent fear memories involve a set of neural systems and molecular genetic factors that, although overlapping, are distinct and dissociable from those subserving contextual fear that is not state bound. We hope that this will stimulate a renewed interest in studying this and other forms of state-dependent memory.
What, if any, are the potential clinical implications of these important insights from laboratory studies in mice? Drugs acting on the GABAergic system, such as diazepam (Valium) and other benzodiazepines, have been mainstays of anti-anxiety medication for decades. However, more recent efforts to develop compounds with refined actions at subpopulations of GABA receptor subtypes did not pan out clinically 11 . The new findings from Jovasevic et al. 6 provide us with a more nuanced appreciation of how GABAergic drugs might affect the mnemonic aspects of anxiety. This is particularly pertinent to the question of improving the utility of cognitivebased strategies such as exposure therapy, often used to treat post-traumatic stress disorder. These strategies rely heavily on learning processes to produce a new, 'safe' memory for a traumatic event 12 and are tightly gated by external context 13 . Benzodiazepines are suspected of interfering with the efficacy of exposure therapy 14 . Could this be in part a result of the generation of a safety memory that is bound to a benzodiazepine-induced state and henceforth liable to failure when a patient is not on the drug? There is already evidence in rodents that this may well be the case 15 .
Looking beyond the GABAergic system, the other major finding is that state-dependent learning offers another in a growing list of behaviors that are linked to the actions of miRNAs. In other fields of medicine, such as in the treatment of cancer, miRNA-based therapeutics are gaining traction. Although this is still a nascent area for psychiatry, exploiting miRNAs to shape brain function and behavior will be an exciting avenue in the coming years.
Parkinson's disease (PD) is a disabling neurodegenerative disorder caused by the progressive loss of dopaminergic systems, resulting in motor and cognitive deficits 1 . An alteration of the neuronal ability to express functional and structural plasticity following dopaminergic denervation in the striatum, the main subcortical station of the basal ganglia, has already been recognized as a key event in PD 2, 3 . Surprisingly, adaptive changes at the level of motor cortex in response to the loss of dopaminergic fibers originating from the midbrain have not yet been characterized. In this issue of Nature Neuroscience, Guo et al. 4 reveal an unexpected dynamic rewiring of neuronal circuits in the primary motor cortex that occurs in various experimental models of PD.
Using transcranial two-photon laser scanning microscopy, the authors studied the temporal evolution of dendritic spines of motor cortex layer V pyramidal neurons, finding marked increases in both spine elimination and formation in these rodent models. Moreover, a pharmacological analysis revealed that the two main dopamine receptors have distinct roles, with the npg
